Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Location contact
Naima Covassin
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06482814
The purpose of this study is to research the effects of partial sleep deprivation (sleep restriction) in a group of individuals whose parents have high blood pressure compared to a group of individuals whose parents have normal blood pressure.
Interested in participating?
Request Info18 year–35 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Naima Covassin
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During the experimental segment the sleep opportunity will be restricted to 5 hours/night. During the acclimation and recovery phases a 9-hour/night sleep opportunity will be provided.
During the normal sleep condition a 9-hour/night sleep opportunity will be provided throughout the 10-day inpatient visit.
Time frame: Day 2, Day 4, Day 7, and Day 9
Systolic Blood pressure will be measured in mmHg
Time frame: Day 2, Day 4, Day 7, and Day 9
Diastolic blood pressure will be measured in mmHg
Time frame: Day 2, Day 4, Day 7, and Day 9
Awake SBP/DBP will be measured in mmHg/mmHg
Time frame: Day 2, Day 4, Day 7, and Day 9
Asleep SBP/DBP will be measured in mmHg/mmHg
Time frame: Day 2, Day 4, Day 7, and Day 9
SBP/DBP Nocturnal dipping will be measured in percent (%)
Time frame: Day 2, Day 4, Day 7, and Day 9
Catecholamines will be measured from a 24-hour urine collection.
Time frame: Day 3, Day 5, Day 8, and Day 10
Baroreflex Sensitivity will be measured from simultaneous electrocardiography (ECG) and noninvasive beat-to-beat BP recording.
Time frame: Day 3, Day 5, Day 8, and Day 10
Endothelial function will be estimated from flow-mediated vasodilation using ultrasound.
Time frame: Day 3, Day 5, Day 8, and Day 10
BP response to stressors will be measured in mmHg
Time frame: Day 3, Day 5, Day 8, and Day 10
Heart Rate response to stressors will be measured by ECG
Time frame: Day 3, Day 5, Day 8, and Day 10
Methylated gene markers in peripheral blood mononuclear cells will be obtained
Time frame: Day 3, Day 5, Day 8, and Day 10
Whole transcriptome in peripheral blood mononuclear cells will be obtained
Time frame: Day 3, Day 5, Day 8, and Day 10
Pulse wave velocity will be measured by Applanation tonometry
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740434
Blood Pressure Monitoring, Ambulatory, Cardiovascular (CV) Risk
Chenôve, France
View Trial DetailsNCT07074145
Adherence Interventions, Behavior
Albuquerque, New Mexico, United States
View Trial DetailsNCT05962372
Abdominal Obesity, Body Weight
San Juan, Puerto Rico
View Trial DetailsNCT07728630
Cardiovascular Diseases, Endothelial Function
Osijek, Croatia
View Trial Details